Navigation Links
Genta Receives Key Patent Related to Oral Gallium Compound G4544
Date:4/14/2008

roval for

Genasense(R) from the U.S. Food and Drug Administration ("FDA") or

European Medicines Agency ("EMEA");

-- the safety and efficacy of the Company's products or product

candidates;

-- the Company's assessment of its clinical trials;

-- the commencement and completion of clinical trials;

-- the Company's ability to develop, manufacture, license and sell its

products or product candidates;

-- the Company's ability to enter into and successfully execute license

and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow

projections, and the Company's ability to obtain sufficient financing

to maintain the Company's planned operations;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such

litigation;

-- the Company's ability to retain compliance with the NASDAQ's listing

qualifications; and

-- the other risks described under Certain Risks and Uncertainties Related

to the Company's Business, as contained in the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2007 and its most recent quarterly report on Form 10-Q.


'/>"/>
SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Genta Incorporated Announces Third Quarter 2007 Financial Results
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Genta Clinical Programs Featured at American Society of Hematology Meeting
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
10. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Apex Medical Corporation (Apex, TWSE: ... Area Care sectors, announces that it is appealing the judgment ... in Germany that found the headgear ... that it has initiated invalidity challenges against various ResMed patents ... counterattacking against trivial and junk patents. ResMed ...
(Date:7/29/2014)... SAN DIEGO , July 29, 2014 /PRNewswire/ ... of Nancy Thornberry to its board ... and franchise head, Diabetes and Endocrinology for Merck ... research, strategy and overall pipeline management in diabetes, ... scientist, initiated and co-led the program that resulted ...
(Date:7/29/2014)... July 29, 2014  Encision Inc. (OTCQB:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... June 30, 2014. The Company posted quarterly ... loss of $202 thousand, or $(0.02) per share. These ... a net loss of $311 thousand, or $(0.04) per ...
Breaking Medicine Technology:Apex Continues Fighting Against Patents to Free Up Competition 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... CHENGDU, China , May 7 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... and sells modernized traditional Chinese medicine,("TCM") and branded generics based in ... call to discuss its fiscal 2010 third,quarter results at 9:00 a.m. ... , , ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today announced its fiscal 2010 third quarter ... on May 6, 2010 , and is payable on June 30, 2010 , to ... , , ... , Hill-Rom is a leading ...
Cached Medicine Technology:Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 2Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 3
(Date:7/29/2014)... 29, 2014 CRN International has promoted ... Operation. , Christina Upton, an 11-year veteran at the ... Services responsible for managing the day-to-day execution of all ... the center of all activities for CRN clients, which ... the world . The department interfaces directly with clients, ...
(Date:7/29/2014)... 2014 Healthcare staffing agency Medical ... of Tomorrow Scholarship Competition winners:, , ... ,     Racheal D., Freshman, Cerritos College in ... Community College in Houston, TX , ... Solutions hosts the Nurses of Tomorrow Scholarship competition ...
(Date:7/29/2014)... July 29, 2014 1WorldSync announces ... leading healthcare suppliers will utilize the Global Data ... information network to share product information with the ... trading partners across their global supply chain. Holger ... at B. Braun: "B. Braun serves customers in ...
(Date:7/29/2014)... Burlington, VT (PRWEB) July 29, 2014 ... image management solutions, announced today the release of ... Portal, version 11.5. , Mach7’s Physician & ... physicians and patients. Patients gain access to a ... imaging files. Mach7 seamlessly consolidates complete patient care ...
(Date:7/29/2014)... Collierville, TN (PRWEB) July 29, 2014 ... to the reimbursement model of all hospitals. Studies show ... tsunami.[1] One simple, easy, low cost tool that ... organizational performance by 20 to 25%. , Their secret? ... to one anther at the end of an operational ...
Breaking Medicine News(10 mins):Health News:CRN International Names New Director to Lead Client Services Department 2Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 3Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 2Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 3Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 3
... , , , , ... Fire Department, will attempt to set the Ohio state record for ... Lebanon, Ohio on September 4, 2009. His mission: To memorialize the ... create awareness about education that exists to prevent these unnecessary deaths. ...
... , MINNEAPOLIS, Sept. 3 ... company that develops, manufactures and markets innovative proprietary products to ... 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT ... is a proprietary, minimally invasive percutaneous tibial nerve stimulation (PTNS) ...
... ... ... September 3, 2009 -- FaxBack®, a leading provider of reliable VoIP fax server solutions ... ATA device, based on HTTPS, which provides a superior level of reliability for VoIP faxes. ...
... ... have entered a partnership to provide TDA members with accounts receivable management services from ... , ... 3, 2009 -- The Texas Dental Association (TDA) has partnered with TekCollect , ...
... ... Studies Personality Traits along with Gender and Generational Differences , ... Alpharetta, GA (Vocus) September 3, 2009 -- ... to dominant personality traits? Jackson & Coker has begun a year-long research study ...
... ... of leading B2B online comparison shopping marketplaces, today announced that 98% of customers would ... profession. , ... NC (PRWEB) September 3, 2009 -- Net32 today reported that dentists have provided the ...
Cached Medicine News:Health News:Firefighter Will Attempt to Set Ohio Record for 100 Consecutive Skydives 2Health News:Firefighter Will Attempt to Set Ohio Record for 100 Consecutive Skydives 3Health News:Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug 2Health News:Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug 3Health News:Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug 4Health News:FaxBack Announces a New VoIP Fax ATA, based on HTTPS, Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 2Health News:Texas Dental Association Offers Premier Accounts Receivable Management Services from TekCollect via TDA Perks Program 2Health News:Physicians' Personalities Provide Clues Regarding Job Satisfaction 2Health News:Physicians' Personalities Provide Clues Regarding Job Satisfaction 3Health News:Physicians' Personalities Provide Clues Regarding Job Satisfaction 4Health News:Net32, Inc. Reports Highest Customer Ratings Ever 2
... Used for catheter or instrument ... features a fabrication process that eliminates ... and introducer dilator, facilitating introduction through ... reinforcement sleeve prevents movement between introducer ...
... Used for temporary internal ... junction to the bladder. ... packages. Intended for one-time ... is advised; C-Flex® and ...
... or instrument introduction. The dual knobs ... away and removed. The maximum diameter ... be introduced should be measured to ... Supplied sterile in peel-open packages. Intended ...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: